We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
-4.33%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$11.8B
AUM Growth
+$319M
Cap. Flow
+$1B
Cap. Flow %
8.54%
Top 10 Hldgs %
23.66%
Holding
2,691
New
325
Increased
1,356
Reduced
628
Closed
97

Sector Composition

Rank Sector Weight
1 Technology 20.64%
2 Healthcare 13.3%
3 Financials 11.85%
4 Consumer Discretionary 9.09%
5 Industrials 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATC
1776
DELISTED
CAMBRIDGE BANCORP
CATC
$44K ﹤0.01%
+500
New +$41.1K
ATEC icon
1777
Alphatec Holdings
ATEC
$1.45B
$43K ﹤0.01%
4,212
+62
+1% +$490
BBSI icon
1778
Barrett Business Services
BBSI
$761M
$43K ﹤0.01%
2,200
BLNK icon
1779
Blink Charging
BLNK
$85.5M
$43K ﹤0.01%
2,930
+340
+13% +$6.98K
COLL icon
1780
Collegium Pharmaceutical
COLL
$843M
$43K ﹤0.01%
2,423
+33
+1% +$582
EXEL icon
1781
Exelixis
EXEL
$12.7B
$43K ﹤0.01%
2,750
-8,370
-75% -$162K
HYFM icon
1782
Hydrofarm Holdings
HYFM
$7.96M
$43K ﹤0.01%
1,680
+1,045
+165% +$33.5K
JOBY icon
1783
Joby Aviation
JOBY
$8.33B
$43K ﹤0.01%
8,986
+196
+2% +$1.07K
MBI icon
1784
MBIA
MBI
$253M
$43K ﹤0.01%
4,692
+57
+1% +$676
SPCE icon
1785
Virgin Galactic
SPCE
$498M
$43K ﹤0.01%
460
+8
+2% +$1.03K
SRPT icon
1786
Sarepta Therapeutics
SRPT
$1.92B
$43K ﹤0.01%
385
-155
-29% -$15.6K
SWTX
1787
DELISTED
SpringWorks Therapeutics
SWTX
$43K ﹤0.01%
1,807
+27
+2% +$774
WMS icon
1788
Advanced Drainage Systems
WMS
$10.8B
$43K ﹤0.01%
370
AVTR icon
1789
Avantor
AVTR
$9.31B
$42K ﹤0.01%
2,120
+1,883
+795% +$50.4K
CEVA icon
1790
CEVA Inc
CEVA
$868M
$42K ﹤0.01%
1,529
-171
-10% -$5.49K
ENTA icon
1791
Enanta Pharmaceuticals
ENTA
$393M
$42K ﹤0.01%
936
-271
-22% -$15.8K
MTZ icon
1792
MasTec
MTZ
$21.9B
$42K ﹤0.01%
548
+88
+19% +$6.81K
STC icon
1793
Stewart Information Services
STC
$2B
$42K ﹤0.01%
1,069
-5,981
-85% -$306K
TBBK icon
1794
The Bancorp
TBBK
$2.83B
$42K ﹤0.01%
1,541
+41
+3% +$950
VCYT icon
1795
Veracyte
VCYT
$3.73B
$42K ﹤0.01%
2,119
+55
+3% +$1.24K
WOW
1796
DELISTED
WideOpenWest
WOW
$42K ﹤0.01%
+3,045
New +$54.3K
LICY
1797
DELISTED
Li-Cycle Holdings Corp.
LICY
$42K ﹤0.01%
875
+15
+2% +$816
BVH
1798
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$42K ﹤0.01%
2,550
PAYA
1799
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$42K ﹤0.01%
5,273
+83
+2% +$546
DVAX
1800
DELISTED
Dynavax Technologies
DVAX
$41K ﹤0.01%
3,588
+88
+3% +$1.15K

Similar funds

Nisa Investment Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Nisa Investment Advisors held 2,691 positions worth $11.8B, up 2.8% from $11.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Nisa Investment Advisors deployed $1B of net new capital in Q3 2022, opening 325 new positions and adding to 1,356 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 2,596,974 shares worth $469M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $19.8M trimmed.

  • Nisa Investment Advisors's largest Q3 2022 buy was Vanguard Morningstar Total Stock Market ETF: 2,596,974 shares worth $469M.
  • Nisa Investment Advisors added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $108M increase.
  • Nisa Investment Advisors's biggest Q3 2022 reduction was iShares National Muni Bond ETF, cutting an estimated $19.8M.
  • Nisa Investment Advisors fully exited Duke Realty Corp. in Q3 2022, selling an estimated $11.9M.
  • Nisa Investment Advisors's ten largest holdings make up 24% of its $11.8B portfolio in Q3 2022.
  • Nisa Investment Advisors opened 325 new positions and closed 97 in Q3 2022.
  • Nisa Investment Advisors's portfolio value rose 2.8% quarter-over-quarter to $11.8B.

Based on Nisa Investment Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.